UK markets open in 6 hours 13 minutes

Coloplast A/S (COLO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
878.00-0.40 (-0.05%)
At close: 04:59PM CET
Currency in DKK

Valuation measures4

Market cap (intra-day) 186.41B
Enterprise value 204.48B
Trailing P/E 39.71
Forward P/E 33.22
PEG ratio (5-yr expected) 4.26
Price/sales (ttm)8.27
Price/book (mrq)22.48
Enterprise value/revenue 9.06
Enterprise value/EBITDA 28.29

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-18.29%
S&P500 52-week change 3-13.51%
52-week high 31,175.00
52-week low 3728.80
50-day moving average 3819.40
200-day moving average 3873.64

Share statistics

Avg vol (3-month) 3179.88k
Avg vol (10-day) 3123.45k
Shares outstanding 5194.31M
Implied shares outstanding 6N/A
Float 8130.81M
% held by insiders 135.90%
% held by institutions 125.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 419
Forward annual dividend yield 42.16%
Trailing annual dividend rate 320.00
Trailing annual dividend yield 32.28%
5-year average dividend yield 42.11
Payout ratio 485.93%
Dividend date 3N/A
Ex-dividend date 409 May 2022
Last split factor 25:1
Last split date 319 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2022
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 20.84%
Operating margin (ttm)30.64%

Management effectiveness

Return on assets (ttm)17.03%
Return on equity (ttm)57.18%

Income statement

Revenue (ttm)22.58B
Revenue per share (ttm)106.25
Quarterly revenue growth (yoy)18.80%
Gross profit (ttm)15.53B
EBITDA 7.54B
Net income avi to common (ttm)4.71B
Diluted EPS (ttm)22.11
Quarterly earnings growth (yoy)-5.70%

Balance sheet

Total cash (mrq)633M
Total cash per share (mrq)2.98
Total debt (mrq)18.71B
Total debt/equity (mrq)225.62
Current ratio (mrq)1.20
Book value per share (mrq)39.06

Cash flow statement

Operating cash flow (ttm)5.1B
Levered free cash flow (ttm)3.75B